G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (“G Medical” or the "Company"), a Telehealth, medical device, and remote patient monitoring company providing clinical-grade solutions for consumers, ...

NEW YORK (Reuters Health) - Given what little we know about the immune response to SARS-CoV-2, it remains unclear what role serologic testing for antibodies to the virus should play, according to a ...

Global Serological Testing Market OverviewThe global serological testing market is projected to grow at a compound annual growth rate (CAGR) of approximately 6–8% through 2027. Market expansion is ...

Such a treatment also may help determine how many people were exposed. With a limited supply of COVID-19 tests in the United States, people with mild symptoms are less likely to be tested, leaving ...

A fascinating new preprint discusses the potential for customized serologic testing in individuals who have or have not been vaccinated against the severe acute respiratory syndrome coronavirus 2 ...

G Medical Innovations Joins Forces with Serology Covid Testing to Support Safer Classroom Learning in California School Districts Amid Omicron Variant Surge 25.01.2022 / 10:03 The issuer is solely ...

Autoantibody assays may have significant differences due to the heterogeneity of autoantibodies, including epitope specificity, isotype, and affinity/avidity. This makes it challenging for clinical ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In the absence ...